| Primary |
| Depression |
60.6% |
| Anxiety |
12.1% |
| Major Depression |
4.9% |
| Bipolar Disorder |
3.6% |
| Pain |
2.9% |
| Hypertension |
2.1% |
| Obsessive-compulsive Disorder |
1.9% |
| Multiple Sclerosis |
1.5% |
| Postpartum Depression |
1.5% |
| Hepatitis C |
1.2% |
| Back Pain |
1.0% |
| Rheumatoid Arthritis |
0.9% |
| Sleep Disorder |
0.9% |
| Dementia Alzheimer's Type |
0.8% |
| Insomnia |
0.8% |
| Panic Attack |
0.8% |
| Suicidal Ideation |
0.8% |
| Generalised Anxiety Disorder |
0.6% |
| Migraine |
0.6% |
| Nasopharyngitis |
0.6% |
|
| Suicidal Ideation |
15.2% |
| Vomiting |
9.7% |
| Tremor |
8.2% |
| Suicide Attempt |
7.1% |
| Maternal Drugs Affecting Foetus |
5.9% |
| Serotonin Syndrome |
5.2% |
| Completed Suicide |
4.8% |
| Weight Increased |
4.8% |
| Treatment Noncompliance |
4.5% |
| Somnolence |
4.1% |
| Weight Decreased |
4.1% |
| Loss Of Consciousness |
3.3% |
| Thinking Abnormal |
3.3% |
| Electrocardiogram Qt Prolonged |
3.0% |
| Overdose |
3.0% |
| Talipes |
3.0% |
| Visual Impairment |
3.0% |
| Anxiety |
2.6% |
| Medication Error |
2.6% |
| Paraesthesia |
2.6% |
|
| Secondary |
| Depression |
36.5% |
| Anxiety |
12.3% |
| Product Used For Unknown Indication |
8.8% |
| Pain |
6.5% |
| Bipolar Disorder |
6.3% |
| Hypertension |
4.7% |
| Drug Use For Unknown Indication |
4.7% |
| Major Depression |
2.7% |
| Insomnia |
2.6% |
| Multiple Sclerosis |
2.4% |
| Foetal Exposure During Pregnancy |
1.6% |
| Back Pain |
1.4% |
| Post-thoracotomy Pain Syndrome |
1.4% |
| Sleep Disorder |
1.4% |
| Panic Attack |
1.3% |
| Smoking Cessation Therapy |
1.2% |
| Drug Exposure During Pregnancy |
1.1% |
| Nausea |
1.1% |
| Post-traumatic Stress Disorder |
1.1% |
| Anger |
1.0% |
|
| Suicidal Ideation |
9.4% |
| Suicide Attempt |
9.0% |
| Weight Increased |
8.6% |
| Tremor |
7.9% |
| Vomiting |
7.3% |
| Drug Hypersensitivity |
7.1% |
| Drug Ineffective |
6.5% |
| Somnolence |
6.3% |
| Post-thoracotomy Pain Syndrome |
4.6% |
| Serotonin Syndrome |
4.0% |
| Withdrawal Syndrome |
4.0% |
| Treatment Noncompliance |
3.6% |
| Encephalopathy |
3.3% |
| Dysphonia |
3.1% |
| Vaginal Haemorrhage |
3.1% |
| Hypoaesthesia |
2.7% |
| Insomnia |
2.5% |
| Nervousness |
2.3% |
| Rash |
2.3% |
| Vertigo |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.2% |
| Depression |
14.9% |
| Drug Use For Unknown Indication |
11.7% |
| Anxiety |
7.3% |
| Pain |
5.8% |
| Hypertension |
4.4% |
| Bipolar Disorder |
4.2% |
| Multiple Sclerosis |
2.8% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Sleep Disorder |
2.6% |
| Hepatitis C |
2.5% |
| Insomnia |
2.5% |
| Crohn's Disease |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Asthma |
1.8% |
| Smoking Cessation Therapy |
1.8% |
| Contraception |
1.8% |
| Osteoporosis |
1.8% |
| Diabetes Mellitus |
1.5% |
| Blood Cholesterol Increased |
1.5% |
|
| Weight Increased |
12.6% |
| Vomiting |
12.4% |
| Type 2 Diabetes Mellitus |
8.9% |
| Weight Decreased |
8.1% |
| Pain |
5.2% |
| Pulmonary Embolism |
4.7% |
| Nausea |
4.7% |
| Suicidal Ideation |
4.5% |
| Vision Blurred |
4.0% |
| Tremor |
3.9% |
| Drug Ineffective |
3.8% |
| Death |
3.4% |
| Somnolence |
3.4% |
| Urinary Tract Infection |
3.2% |
| Pneumonia |
3.1% |
| Rash |
3.0% |
| Fatigue |
2.9% |
| White Blood Cell Count Decreased |
2.8% |
| Pancreatitis |
2.7% |
| Wrong Technique In Drug Usage Process |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
19.1% |
| Depression |
18.0% |
| Drug Use For Unknown Indication |
10.1% |
| Bipolar Disorder |
6.7% |
| Pain |
5.6% |
| Neuropathy Peripheral |
5.1% |
| Anxiety |
4.5% |
| Smoking Cessation Therapy |
3.9% |
| Back Pain |
3.4% |
| Gout |
3.4% |
| Arthritis |
2.8% |
| Asthma |
2.8% |
| Cardiac Disorder |
2.8% |
| Ill-defined Disorder |
2.8% |
| Bronchitis Chronic |
2.2% |
| Atrial Fibrillation |
1.7% |
| Chronic Myeloid Leukaemia |
1.7% |
| Ankylosing Spondylitis |
1.1% |
| Convulsion |
1.1% |
| Drug Dependence |
1.1% |
|
| Drug Interaction |
15.2% |
| Drug Toxicity |
15.2% |
| Vomiting |
10.9% |
| Loss Of Consciousness |
8.7% |
| Dyspnoea |
4.3% |
| Feeling Abnormal |
4.3% |
| Nodule |
4.3% |
| Serotonin Syndrome |
4.3% |
| Tremor |
4.3% |
| Weight Decreased |
4.3% |
| Yawning |
4.3% |
| Agitation |
2.2% |
| Anticonvulsant Drug Level Increased |
2.2% |
| Anxiety |
2.2% |
| Dysphagia |
2.2% |
| Gas Poisoning |
2.2% |
| Grand Mal Convulsion |
2.2% |
| Head Injury |
2.2% |
| Headache |
2.2% |
| Heart Rate Increased |
2.2% |
|
